Skip to main content
. Author manuscript; available in PMC: 2017 Jun 1.
Published in final edited form as: Parkinsonism Relat Disord. 2016 Apr 9;27:54–60. doi: 10.1016/j.parkreldis.2016.04.007

Table 1.

Characteristics of Uniform Data Set sample at baseline

Characteristics at baseline visit* PD-MCI n=41 AD-MCI n=191 p-value
Number of visits, mean (SD) 3.5 (1.5) 3.3 (1.3) 0.51
Age at baseline (years), mean (SD) 70.2 (8.5) 79.1 (10.3) <.001
Education (years), mean (SD) 16.0 (2.5) 15.6 (3.1) 0.40
Male, n (%) 25 (61.0%) 95 (49.7%) 0.19
Non-white race, n (%) 3 (7.3%) 34 (18.0%) 0.10
Age of cognitive decline onset, mean (SD) 67.6 (9.3) 76.5 (10.8) <.001
Memory domain affected 26 (63.4%) 182 (95.3%) <.001
Language domain affected 2 (4.9%) 29 (15.2%) 0.13
Attention domain affected 16 (39.0%) 16 (8.4%) <.001
Executive function domain affected 24 (58.5%) 65 (34.0%) 0.003
Visuospatial domain affected 5 (12.2%) 10 (5.2%) 0.10
≥1 APOE e4 allele, n (%) 7 (20.6%) 64 (41.8%) 0.02
Age at PD diagnosis, mean (SD) 62.2 (9.9) NA NA

Abbreviations: PD-MCI = mild cognitive impairment due to Parkinson's disease; AD-MCI = mild cognitive impairment due to Alzheimer's disease; SD = standard deviation; APOE = apolipoprotein E; PD = Parkinson's disease; NA = Not applicable

*

Number of participants missing data (PD-MCI, AD-MCI): Education (0,1), race (0,2), age of cognitive decline onset (0,19), APOE genotype (7,38), age of PD diagnosis (3,not applicable)

based on clinician's assessment